ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

HAI Delivery Extends Survival In Patients With Liver Metastasis

March 31, 2006

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007